Get started
Author

Julia Hoefer

Observed names: Hoefer, Julia, J Hoefer, J. Hoefer, Julia Höfer
ORCID: 0000-0003-1138-3134
Observed ORCID: 0000-0003-1138-3134
OpenAlex ID: A5011027377
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
2012 · Martin Puhr, Julia Hoefer, et al. · American Journal Of Pathology · 269
PDF
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2017 · Martin Puhr, Julia Hoefer, et al. · Clinical Cancer Research · 185
PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
2012 · Julia Hoefer, Georg Schäfer, et al. · American Journal Of Pathology · 86
Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide
2016 · Julia Hoefer, Mohammady Akbor, et al. · Oncotarget · 57
PDF
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer
2013 · Julia Hoefer, Johann Kern, et al. · Endocrine Related Cancer · 53
PDF
The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice
2010 · Ivan Tancevski, Egon Demetz, et al. · PLoS ONE · 53
PDF
The “Aging Factor” Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor’s Age
2017 · Julia Hoefer, Markus Luger, et al. · Frontiers in Aging Neuroscience · 48
PDF
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
2015 · M Puhr, J Hoefer, et al. · Oncogene · 48
PDF
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
2018 · Florian Handle, Martin Puhr, et al. · Molecular Cancer Therapeutics · 45
PDF
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells
2016 · Florian Handle, Holger H.H. Erb, et al. · Molecular Cancer Research · 43
Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate
2015 · Andrea Dueregger, Bernd Schöpf, et al. · PLoS ONE · 40
PDF
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
2014 · Martin Puhr, Julia Hoefer, et al. · Oncotarget · 38
PDF
The thyromimetic T-0681 protects from atherosclerosis
2008 · Ivan Tancevski, Andreas Wehinger, et al. · Journal of Lipid Research · 34
Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2
2014 · Ivan Tancevski, Manfred Nairz, et al. · EMBO Molecular Medicine · 33
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer
2021 · Martin Puhr, Andrea Eigentler, et al. · Oncogene · 31
PDF
Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer
2020 · Mona Kafka, Fabian Mayr, et al. · Cancers · 26
PDF
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?
2015 · Isabel Heidegger, Julia Höfer, et al. · The Prostate · 23
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts
2023 · Andrea Eigentler, Florian Handle, et al. · Oncogene · 21
PDF
Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner
2011 · Shahrokh F. Shariat, Thomas F. Chromecki, et al. · The Journal of Urology · 17
The ‘rejuvenating factor’ TIMP‐2 is detectable in human blood components for transfusion
2020 · Julia Hoefer, Christian Dal‐Pont, et al. · Vox Sanguinis · 5
PDF
Figure S1 from The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
2023 · Martin Puhr, Julia Hoefer, et al. · 1
PDF
Critical Role of Androgen Receptor Level in Prostate Cancer Cell Resistance to New Generation Antiandrogen Enzalutamide
2016 · Julia Hoefer, Mohammady Akbor, et al. · Endocrine Abstracts · 1
Supplementary Figure 5 from The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
2023 · Florian Handle, Martin Puhr, et al.
Supplementary Figure 2 from The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
2023 · Florian Handle, Martin Puhr, et al.
Supplementary Figure 4 from The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
2023 · Florian Handle, Martin Puhr, et al.
Works count: 72
Citation count: 1,157
H-index: 18
I10-index: 19
Year
Topic
Type